Medicines Control Council approves Tarceva® in South Africa for treatment of non-small cell lung cancer

Authors

  • Editorial Office

Abstract

Thousands of South African lung cancer patients could now live longer and with improved quality of life if they receive Tarceva

 

® (erlonitib), a novel alternative to traditional chemotherapy, recently approved by the Medicines Control Council (MCC).

Downloads

Issue

Vol. 1 No. 2 (2009)

Section

Press Releases

License

By submitting manuscripts to SAJGO, authors of original articles are assigning copyright to the South African Society of Gynaecologic Oncology (SASGO). Authors may use their own work after publication without written permission, provided they acknowledge the original source. Individuals and academic institutions may freely copy and distribute articles published in SAJGO for educational and research purposes without obtaining permission.